FCGR3A and rheumatoid arthritis: As seen in Figure 6A, the concentration of sCD62P, a biomarker of activated platelets, was significantly increased in plasma of RA patients compared with that of healthy controls, implicating activated platelets in the induction of CD16 on classical monocytes in RA.